Restylane Perlane Lidocaine

DEVICE3 trials

Sponsors

Galderma R&D, Yooyoung Pharmaceutical Co., Ltd.

Conditions

Midface Volume DeficitNasolabial FoldWrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial Folds

Phase 3

Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds

CompletedNCT03170050

Yooyoung Pharmaceutical Co., Ltd.Wrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial Folds

Start: 2017-03-01End: 2017-11-21Updated: 2021-05-10

Unknown Phase

Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency

CompletedNCT03097783

Galderma R&DMidface Volume Deficit

Start: 2017-04-26End: 2018-09-14Updated: 2023-11-03

Pain and Safety of Restylane Perlane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds

CompletedNCT03174132

Galderma R&DNasolabial Fold

Start: 2017-09-21End: 2018-01-16Updated: 2022-08-26

Related Papers

Lifting the midface using a hyaluronic acid filler with lidocaine: A randomized multi‐center study in a Chinese population

Journal of Cosmetic Dermatology2022-08-0410 citations